Published in J Membr Biol on November 14, 2008
Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane. Antimicrob Agents Chemother (2012) 0.94
Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5. Antimicrob Agents Chemother (2011) 0.91
The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions. J Biol Chem (2014) 0.89
Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain. J Biol Chem (2010) 0.86
Biosensor applications in the field of antibiotic research--a review of recent developments. Sensors (Basel) (2011) 0.86
Isotope-assisted screening for iron-containing metabolites reveals a high degree of diversity among known and unknown siderophores produced by Trichoderma spp. Appl Environ Microbiol (2012) 0.82
An association between peptidoglycan synthesis and organization of the Streptococcus pyogenes ExPortal. MBio (2013) 0.79
Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors. J Biol Chem (2012) 0.77
Highly efficient Staphylococcus carnosus mutant selection system based on suicidal bacteriocin activation. Appl Environ Microbiol (2011) 0.76
Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother (1985) 3.83
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol (2004) 2.36
Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem (1988) 2.32
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem (2003) 2.26
Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci (2005) 2.21
Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry (1995) 2.10
In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol (2004) 1.81
Assembly and stability of nisin-lipid II pores. Biochemistry (2004) 1.60
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem (1997) 1.59
Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal Biochem (1994) 1.40
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother (2006) 1.36
Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin. Biochemistry (2002) 1.31
Staphylococcus succinus sp. nov., isolated from Dominican amber. Int J Syst Bacteriol (1998) 1.29
Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek (1999) 1.25
Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin. FEBS Lett (1996) 1.08
FATTY ACID COMPOSITION OF LIPIDS FROM STREPTOCOCCUS CREMORIS AND STREPTOCOCCUS LACTIS VAR. MALTIGENES. J Bacteriol (1963) 1.01
Cellular Fatty Acid profiles of lactobacillus and lactococcus strains in relation to the oleic Acid content of the cultivation medium. Appl Environ Microbiol (1995) 0.99
The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques. Biochim Biophys Acta (2006) 0.96
Binding of Nisin Z to bilayer vesicles as determined with isothermal titration calorimetry. Biochemistry (2000) 0.90
The detection of UV-induced membrane damages by a combination of two biosensor techniques. Photochem Photobiol (2005) 0.80
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 10.15
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol (2006) 4.29
Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother (2007) 3.54
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med (2005) 3.40
The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol (2006) 2.53
Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science (2010) 2.50
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann N Y Acad Sci (2012) 1.91
Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides. Science (2012) 1.84
In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol (2004) 1.81
MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett (2004) 1.81
Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist (2002) 1.69
Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol (2008) 1.60
Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun (2010) 1.48
Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol (2003) 1.48
An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway. Int J Med Microbiol (2009) 1.43
Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics (2009) 1.39
Chitosan and its antimicrobial potential--a critical literature survey. Microb Biotechnol (2009) 1.38
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother (2006) 1.36
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother (2004) 1.35
Analysis of the matrix-assisted laser desorption ionization-time of flight mass spectrum of Staphylococcus aureus identifies mutations that allow differentiation of the main clonal lineages. J Clin Microbiol (2013) 1.34
The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J Biol Chem (2002) 1.30
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J Biol Chem (2003) 1.25
Small cationic antimicrobial peptides delocalize peripheral membrane proteins. Proc Natl Acad Sci U S A (2014) 1.22
Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc Natl Acad Sci U S A (2011) 1.22
Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. Nat Prod Rep (2011) 1.21
Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II. J Biol Chem (2010) 1.19
Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed? Mol Microbiol (2009) 1.18
Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J Bacteriol (2004) 1.17
Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One (2009) 1.14
Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5. Appl Environ Microbiol (2004) 1.07
Role of the single regulator MrsR1 and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. Appl Environ Microbiol (2002) 1.07
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem J (2005) 1.05
Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int J Med Microbiol (2008) 1.05
Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. Microb Drug Resist (2012) 1.04
Lipid II and other bactoprenol-bound cell wall precursors as drug targets. Curr Opin Investig Drugs (2010) 1.04
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol (2006) 1.01
Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One (2012) 1.01
Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J Mol Biol (2002) 0.98
Combination of antibiotic mechanisms in lantibiotics. Farmaco (2002) 0.97
Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches. Thromb Haemost (2008) 0.97
Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides. Biochemistry (2008) 0.97
The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques. Biochim Biophys Acta (2006) 0.96
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim Biophys Acta (2008) 0.96
Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J Am Chem Soc (2012) 0.96
Functional analysis of the cytoskeleton protein MreB from Chlamydophila pneumoniae. PLoS One (2011) 0.96
Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II. Appl Environ Microbiol (2008) 0.96
Characterization of co-translationally formed nanodisc complexes with small multidrug transporters, proteorhodopsin and with the E. coli MraY translocase. Biochim Biophys Acta (2012) 0.95
Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane. Antimicrob Agents Chemother (2012) 0.94
Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo. Mol Cancer Ther (2011) 0.93
Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Peptides (2005) 0.93
Preparative scale cell-free production and quality optimization of MraY homologues in different expression modes. J Biol Chem (2011) 0.92
The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol (2008) 0.92
Requirement of lipid II biosynthesis for cell division in cell wall-less Wolbachia, endobacteria of arthropods and filarial nematodes. Int J Med Microbiol (2013) 0.91
The sarcomeric Z-disc component myopodin is a multiadapter protein that interacts with filamin and alpha-actinin. Eur J Cell Biol (2010) 0.90
Artificial beta-defensin based on a minimal defensin template. Biochem J (2009) 0.90
Cytoplasmic sulfurtransferases in the purple sulfur bacterium Allochromatium vinosum: evidence for sulfur transfer from DsrEFH to DsrC. PLoS One (2012) 0.89
The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions. J Biol Chem (2014) 0.89
The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives. Thromb Res (2011) 0.89
Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes. J Biol Chem (2012) 0.88
Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl Environ Microbiol (2002) 0.87
Antibiotic-induced autoactivation of IS256 in Staphylococcus aureus. Antimicrob Agents Chemother (2013) 0.87
The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis. PLoS One (2012) 0.87
Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro. Int J Clin Pharmacol Ther (2013) 0.87
New strategies and compounds for anti-infective treatment. Curr Opin Microbiol (2013) 0.87
Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action. J Biol Chem (2012) 0.86
Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42. PLoS One (2011) 0.86
Lahorenoic acids A-C, ortho-dialkyl-substituted aromatic acids from the biocontrol strain Pseudomonas aurantiaca PB-St2. J Nat Prod (2013) 0.86
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro. Int J Pharm (2010) 0.86
Biosensor applications in the field of antibiotic research--a review of recent developments. Sensors (Basel) (2011) 0.86
Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis. Int J Cancer (2014) 0.86
Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B. Antimicrob Agents Chemother (2011) 0.85
Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents. J Med Chem (2012) 0.84
Functional microdomains of glycolipids with partially fluorinated membrane anchors: impact on cell adhesion. Chemphyschem (2004) 0.84
Binding between heparin and the integrin VLA-4. Thromb Haemost (2009) 0.83
Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups. Beilstein J Org Chem (2012) 0.83
Anti-infective strategies of the future: is there room for species-specific antibacterial agents? Curr Pharm Des (2010) 0.83
Analysis of SM4 sulfatide as a P-selectin ligand using model membranes. Biophys Chem (2010) 0.82
Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery. Biochim Biophys Acta (2007) 0.82
PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions. J Invest Dermatol (2008) 0.82
Cooperation between lateral ligand mobility and accessibility for receptor recognition in selectin-induced cell rolling. Biochemistry (2002) 0.81
Analysis of membrane interactions of antibiotic peptides using ITC and biosensor measurements. Biophys Chem (2010) 0.81
Antimicrobial Peptides from the Aurein Family Form Ion-Selective Pores in Bacillus subtilis. Chembiochem (2015) 0.81
Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Arch Biochem Biophys (2005) 0.81
Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. Biochem Pharmacol (2013) 0.81
Very low ethanol concentrations affect the viability and growth recovery in post-stationary-phase Staphylococcus aureus populations. Appl Environ Microbiol (2006) 0.80
Model membrane studies for characterization of different antibiotic activities of lipopeptides from Pseudomonas. Biochim Biophys Acta (2011) 0.80
Affinity and kinetics of different heparins binding to P- and L-selectin. Semin Thromb Hemost (2007) 0.80
Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity. Biochim Biophys Acta (2013) 0.80